Results 251 to 260 of about 25,935 (265)

Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas

Nature Medicine, 2018
Louai Labanieh, Robbie G Majzner, Esther Hulleman   +2 more
exaly  

GD2-Targeted Immunotherapy of Neuroblastoma

2019
Jung-Tung Hung, Alice L. Yu
openaire   +1 more source

Phase diagram Al-Fe-Gd2

2005
Y. Kawazoe, T. Masumoto, K. Suzuki, A. Inoue, A.-P. Tsai, J.-Z. Yu, T. Aihara Jr., T. Nakanomyo   +7 more
openaire   +1 more source

Disialoganglioside GD2 as a therapeutic target for human diseases

Expert Opinion on Therapeutic Targets, 2015
Maya Suzuki, Nai-Kong V Cheung
exaly  

Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

Nature
Liora Schultz, Valentin Barsan, Shabnum Patel   +2 more
exaly  

Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8

Journal of Controlled Release, 2017
Carles Monterrubio, Guillem Pascual-Pasto, Maria Cuadrado-Vilanova   +2 more
exaly  

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Case Medical Research, 2019
openaire   +1 more source

Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults

Pediatric Blood and Cancer, 2016
Irina Ostrovnaya, Irene Y Cheung, Nai-Kong V Cheung   +2 more
exaly  

Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma

Nature Medicine
Francesca Del Bufalo, Biagio De Angelis, Franco Locatelli   +2 more
exaly  

Monoclonal Antibody GD2 Anti-Idiotype Vaccine

2020
openaire   +1 more source